NOVAVAX INC (NVAX) Operating margin 2016–2025
NOVAVAX INC (NVAX) operating margin by fiscal year — reported operating income divided by reported revenue.
40.3%FY2025 · since FY2016: -1752.8% → 40.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 40.3% | +76.8 pp |
| FY2024 | -36.5% | +21.1 pp |
| FY2023 | -57.6% | -25.1 pp |
| FY2022 | -32.5% | +114.6 pp |
| FY2021 | -147.1% | -59.5 pp |
| FY2020 | -87.6% | +558.5 pp |
| FY2019 | -646.1% | -138.9 pp |
| FY2018 | -507.2% | +43.5 pp |
| FY2017 | -550.8% | +1202.1 pp |
| FY2016 | -1752.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX RevenueNVAX Net incomeNVAX Net marginNVAX Gross profitNVAX Gross marginNVAX Operating incomeNVAX Operating cash flowNVAX Free cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →